$MNKD Recent Headlines Skullcandy gains on upg
Post# of 102233
Posted On: 08/24/2014 10:37:37 AM
$MNKD Recent Headlines
Skullcandy gains on upgrade,Tesla reverses gains 2:37 p.m. Aug. 12, 2014 - Sue Chang
U.S. small caps lead broad stock-market gains 4:09 p.m. Aug. 11, 2014 - Anora Mahmudova
Kinder Morgan soars, Tesla rallies on upgrade 12:46 p.m. Aug. 11, 2014 - Sue Chang
MannKind shares soar on Sanofi deal; investors ignore earnings report 10:10 a.m. Aug. 11, 2014 - Russ Britt
Super-Moon illusion or buy the dips on this stock market? 7:52 a.m. Aug. 11, 2014 - Barbara Kollmeyer
MannKind shares soar 23% on Sanofi deal over Afrezza 7:04 a.m. Aug. 11, 2014 - Silvia Ascarelli
Sanofi, MannKind to commercialize Afrezza insulin therapy 5:32 a.m. Aug. 11, 2014 - Silvia Ascarelli
Puma Biotech’s blast-off is not a typical short squeeze 12:10 p.m. July 23, 2014 - Tomi Kilgore
S&P 500 posts strongest 2nd quarter since 2009: Stock market live blog recap 3:33 p.m. June 30, 2014 - blogs.marketwatch.com
MannKind, GoPro rise; Yahoo gains on upgrade 12:02 p.m. June 30, 2014 - Sue Chang
MannKind shares up 23.1% in premarket trade 7:19 a.m. June 30, 2014 - Ciara Linnane
Six more bull months ahead, and GoPro keeps on going 6:28 a.m. June 30, 2014 - Sara Sjolin
MannKind wins approval for its inhaled insulin — and its stock drops? 4:30 p.m. June 27, 2014 - Russ Britt
DuPont falls on outlook; Michaels debuts 4:08 p.m. June 27, 2014 - Sue Chang
3 overlooked stocks loved by top-ranked advisers 3:09 p.m. April 25, 2014 - Mark Hulbert
Tesla, Facebook seesaw; Questcor surges on deal 3:54 p.m. April 7, 2014 - Sue Chang
MannKind drops after FDA says its review on drug will last until July 1:46 p.m. April 7, 2014 - Russ Britt
Stock futures drop as earnings season looms 9:20 a.m. April 7, 2014 - Sara Sjolin
MannKind drops 12% after FDA review extension 7:15 a.m. April 7, 2014 - Ben Eisen
MannKind drops 16% after FDA review extension 7:01 a.m. April 7, 2014 - Ben Eisen
How Sanofi's Growth Strategy Will Catapult Afrezza Into a Blockbuster Drug 12:43 p.m. Aug. 20, 2014 - GuruFocus.com
MannKind Corporation: Back To The Fundamentals 11:50 a.m. Aug. 20, 2014 - Seeking Alpha
Revisiting Arena, Orexigen, And VIVUS: Shareholders Can Recoup Their Losses By Invest In MannKind 2:31 p.m. Aug. 19, 2014 - GuruFocus.com
Hottest Healthcare Stocks Now – CLDX KND PDLI MNKD 7:30 a.m. Aug. 19, 2014 - InvestorPlace.com
MannKind Corp. And The Folly Of Cult Biotech Stocks 8:51 a.m. Aug. 18, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – LCI HMSY CBPO MNKD 8:45 a.m. Aug. 18, 2014 - InvestorPlace.com
5 Stocks With Awful Sales Growth — HTS MITT UEC MNKD CTEL 4:00 a.m. Aug. 18, 2014 - InvestorPlace.com
Evaluating MannKind (MNKD) & Sanofi (SNY) Agreement for Afrezza 8:59 a.m. Aug. 15, 2014 - GuruFocus.com
10 Known Unknowns That Matter For MannKind Investors 4:45 p.m. Aug. 14, 2014 - Seeking Alpha
There is a Tide in the Affairs of MannKind: When Taken At the Flood, Will Lead to Fortune 3:38 p.m. Aug. 14, 2014 - GuruFocus.com
10 Cheap Stocks to Buy Now Under $10 10:20 a.m. Aug. 14, 2014 - InvestorPlace.com
Properly Treating Costs: Re-Evaluating The MannKind And Sanofi Partnership 4:53 p.m. Aug. 13, 2014 - Seeking Alpha
Blame MannKind's Fall on its Bloated Balance Sheet 12:04 p.m. Aug. 13, 2014 - TheStreet.com
Update: MannKind Q2 Earnings - Stock Sent To The Woodshed 10:14 a.m. Aug. 13, 2014 - Seeking Alpha
A Deeper Look At MannKind - Sanofi Deal And Valuation 10:02 a.m. Aug. 13, 2014 - Seeking Alpha
What the Market is Telling MannKind 9:00 a.m. Aug. 13, 2014 - 247WallSt.com
MannKind Corporation (MNKD): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. Aug. 13, 2014 - Zacks.com
Cramer's Mad Money - These 2 Sectors Have A Huge Void (8/12/14) 6:09 a.m. Aug. 13, 2014 - Seeking Alpha
MannKind Posts Wider Q2 Loss, Up on Sanofi Deal for Afrezza - Analyst Blog 11:05 a.m. Aug. 12, 2014 - Zacks.com
MannKind: Looking Beyond The Short-Term Disappointment 10:00 a.m. Aug. 12, 2014 - Seeking Alpha
Drug Approvals & Updates, Licensing Agreements, and Upcoming Conferences - Research Reports on Tekmira, MannKind, Eli Lilly, GSK and Cigna 8:30 a.m. Aug. 14, 2014 - PR Newswire - PRF
Critical Alerts For MannKind, Kinder Morgan, Kohls, Maxim Integrated Products and United Technologies. Released By InvestorsObserver 9:31 a.m. Aug. 12, 2014 - PR Newswire - PRF
MannKind Corporation Reports 2014 Second Quarter Financial Results 9:01 a.m. Aug. 11, 2014 - GlobeNewswire
Sanofi and MannKind Announce Global Licensing Agreement for Afrezza® (insulin human) Rapid-Acting Inhaled Insulin 7:00 a.m. Aug. 11, 2014 - PR Newswire - PRF
Sanofi and MannKind Announce Global Licensing Agreement for Afrezza(R) (insulin human) Rapid-Acting Inhaled Insulin 1:13 a.m. Aug. 11, 2014 - GlobeNewswire
MannKind Corporation to Hold 2014 Second Quarter Financial Results Conference Call on August 11, 2014 5:00 p.m. Aug. 5, 2014 - GlobeNewswire
Biotech Stocks Technical Data -- MannKind, ARIAD Pharma, Galena Biopharma, Geron, and Peregrine Pharma 9:00 a.m. Aug. 1, 2014 - PR Newswire - PRF
Critical Alerts For MannKind, CVS Caremark, Express Scripts, Cheniere Energy, and HomeAway Released By InvestorsObserver 9:31 a.m. July 21, 2014 - PR Newswire - PRF
NDA Submission, Results Release Schedules, FDA Grants and Approvals, and Agreements - Analyst Notes on Gilead, Biogen Idec, Amgen, Illumina and MannKind 5:20 a.m. July 4, 2014 - PR Newswire - PRF
MannKind Corp Analyst Report; Afrezza is Approved and Future Developments by BrokerBank Securities, Inc. 11:15 a.m. July 3, 2014 - PR Newswire - PRF
Critical Alerts For MannKind, AOL, Plug Power, Ctrip.com, and 58.com Released By InvestorsObserver 9:31 a.m. July 1, 2014 - PR Newswire - PRF
MannKind Corporation Announces FDA Approval of AFREZZA(R); A Novel, Rapid-Acting Inhaled Insulin for the Treatment of Diabetes 5:07 p.m. June 27, 2014 - GlobeNewswire
Leadership Appointments, Approved Acquisitions, Licensing Agreements, Technical UPdate, and Response to Tender Offer Announcement - Analyst Notes on Actavis, Forest, Vertex, MannKind and Gentiva 5:20 a.m. June 26, 2014 - PR Newswire - PRF
Critical Alerts For Netflix, MannKind, Dish Network, Illumina, and Anheuser-Busch InBev Technology Released By InvestorsObserver 9:31 a.m. June 6, 2014 - PR Newswire - PRF
MannKind to Present at Upcoming Conferences 9:01 a.m. May 27, 2014 - GlobeNewswire
Reveal Insider Trading for Facebook, MannKind, QUALCOMM, American Realty Capital Properties, salesforce.com, and Symantec 8:55 a.m. May 22, 2014 - PR Newswire - PRF
Technical Data on Top Gainers -- Research on MannKind, Intermolecular, FireEye, and Yingli Green Energy Holding 9:10 a.m. May 20, 2014 - PR Newswire - PRF
Earnings Release Results, and Leadership Appointments - Analyst Notes on Halozyme, MannKind, Arrowhead, Idera and BioCryst 7:00 a.m. May 16, 2014 - PR Newswire - PRF
Critical Alerts For Citigroup, Linn Energy, MannKind, Canadian Solar, and Qualcomm Released By InvestorsObserver 9:31 a.m. May 15, 2014 - PR Newswire - PRF
MannKind Corporation Pending FDA Approval Inspires Analyst Report by BrokerBank Securities, Inc. 8:00 a.m. May 14, 2014 - PR Newswire - PRF
Skullcandy gains on upgrade,Tesla reverses gains 2:37 p.m. Aug. 12, 2014 - Sue Chang
U.S. small caps lead broad stock-market gains 4:09 p.m. Aug. 11, 2014 - Anora Mahmudova
Kinder Morgan soars, Tesla rallies on upgrade 12:46 p.m. Aug. 11, 2014 - Sue Chang
MannKind shares soar on Sanofi deal; investors ignore earnings report 10:10 a.m. Aug. 11, 2014 - Russ Britt
Super-Moon illusion or buy the dips on this stock market? 7:52 a.m. Aug. 11, 2014 - Barbara Kollmeyer
MannKind shares soar 23% on Sanofi deal over Afrezza 7:04 a.m. Aug. 11, 2014 - Silvia Ascarelli
Sanofi, MannKind to commercialize Afrezza insulin therapy 5:32 a.m. Aug. 11, 2014 - Silvia Ascarelli
Puma Biotech’s blast-off is not a typical short squeeze 12:10 p.m. July 23, 2014 - Tomi Kilgore
S&P 500 posts strongest 2nd quarter since 2009: Stock market live blog recap 3:33 p.m. June 30, 2014 - blogs.marketwatch.com
MannKind, GoPro rise; Yahoo gains on upgrade 12:02 p.m. June 30, 2014 - Sue Chang
MannKind shares up 23.1% in premarket trade 7:19 a.m. June 30, 2014 - Ciara Linnane
Six more bull months ahead, and GoPro keeps on going 6:28 a.m. June 30, 2014 - Sara Sjolin
MannKind wins approval for its inhaled insulin — and its stock drops? 4:30 p.m. June 27, 2014 - Russ Britt
DuPont falls on outlook; Michaels debuts 4:08 p.m. June 27, 2014 - Sue Chang
3 overlooked stocks loved by top-ranked advisers 3:09 p.m. April 25, 2014 - Mark Hulbert
Tesla, Facebook seesaw; Questcor surges on deal 3:54 p.m. April 7, 2014 - Sue Chang
MannKind drops after FDA says its review on drug will last until July 1:46 p.m. April 7, 2014 - Russ Britt
Stock futures drop as earnings season looms 9:20 a.m. April 7, 2014 - Sara Sjolin
MannKind drops 12% after FDA review extension 7:15 a.m. April 7, 2014 - Ben Eisen
MannKind drops 16% after FDA review extension 7:01 a.m. April 7, 2014 - Ben Eisen
How Sanofi's Growth Strategy Will Catapult Afrezza Into a Blockbuster Drug 12:43 p.m. Aug. 20, 2014 - GuruFocus.com
MannKind Corporation: Back To The Fundamentals 11:50 a.m. Aug. 20, 2014 - Seeking Alpha
Revisiting Arena, Orexigen, And VIVUS: Shareholders Can Recoup Their Losses By Invest In MannKind 2:31 p.m. Aug. 19, 2014 - GuruFocus.com
Hottest Healthcare Stocks Now – CLDX KND PDLI MNKD 7:30 a.m. Aug. 19, 2014 - InvestorPlace.com
MannKind Corp. And The Folly Of Cult Biotech Stocks 8:51 a.m. Aug. 18, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – LCI HMSY CBPO MNKD 8:45 a.m. Aug. 18, 2014 - InvestorPlace.com
5 Stocks With Awful Sales Growth — HTS MITT UEC MNKD CTEL 4:00 a.m. Aug. 18, 2014 - InvestorPlace.com
Evaluating MannKind (MNKD) & Sanofi (SNY) Agreement for Afrezza 8:59 a.m. Aug. 15, 2014 - GuruFocus.com
10 Known Unknowns That Matter For MannKind Investors 4:45 p.m. Aug. 14, 2014 - Seeking Alpha
There is a Tide in the Affairs of MannKind: When Taken At the Flood, Will Lead to Fortune 3:38 p.m. Aug. 14, 2014 - GuruFocus.com
10 Cheap Stocks to Buy Now Under $10 10:20 a.m. Aug. 14, 2014 - InvestorPlace.com
Properly Treating Costs: Re-Evaluating The MannKind And Sanofi Partnership 4:53 p.m. Aug. 13, 2014 - Seeking Alpha
Blame MannKind's Fall on its Bloated Balance Sheet 12:04 p.m. Aug. 13, 2014 - TheStreet.com
Update: MannKind Q2 Earnings - Stock Sent To The Woodshed 10:14 a.m. Aug. 13, 2014 - Seeking Alpha
A Deeper Look At MannKind - Sanofi Deal And Valuation 10:02 a.m. Aug. 13, 2014 - Seeking Alpha
What the Market is Telling MannKind 9:00 a.m. Aug. 13, 2014 - 247WallSt.com
MannKind Corporation (MNKD): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. Aug. 13, 2014 - Zacks.com
Cramer's Mad Money - These 2 Sectors Have A Huge Void (8/12/14) 6:09 a.m. Aug. 13, 2014 - Seeking Alpha
MannKind Posts Wider Q2 Loss, Up on Sanofi Deal for Afrezza - Analyst Blog 11:05 a.m. Aug. 12, 2014 - Zacks.com
MannKind: Looking Beyond The Short-Term Disappointment 10:00 a.m. Aug. 12, 2014 - Seeking Alpha
Drug Approvals & Updates, Licensing Agreements, and Upcoming Conferences - Research Reports on Tekmira, MannKind, Eli Lilly, GSK and Cigna 8:30 a.m. Aug. 14, 2014 - PR Newswire - PRF
Critical Alerts For MannKind, Kinder Morgan, Kohls, Maxim Integrated Products and United Technologies. Released By InvestorsObserver 9:31 a.m. Aug. 12, 2014 - PR Newswire - PRF
MannKind Corporation Reports 2014 Second Quarter Financial Results 9:01 a.m. Aug. 11, 2014 - GlobeNewswire
Sanofi and MannKind Announce Global Licensing Agreement for Afrezza® (insulin human) Rapid-Acting Inhaled Insulin 7:00 a.m. Aug. 11, 2014 - PR Newswire - PRF
Sanofi and MannKind Announce Global Licensing Agreement for Afrezza(R) (insulin human) Rapid-Acting Inhaled Insulin 1:13 a.m. Aug. 11, 2014 - GlobeNewswire
MannKind Corporation to Hold 2014 Second Quarter Financial Results Conference Call on August 11, 2014 5:00 p.m. Aug. 5, 2014 - GlobeNewswire
Biotech Stocks Technical Data -- MannKind, ARIAD Pharma, Galena Biopharma, Geron, and Peregrine Pharma 9:00 a.m. Aug. 1, 2014 - PR Newswire - PRF
Critical Alerts For MannKind, CVS Caremark, Express Scripts, Cheniere Energy, and HomeAway Released By InvestorsObserver 9:31 a.m. July 21, 2014 - PR Newswire - PRF
NDA Submission, Results Release Schedules, FDA Grants and Approvals, and Agreements - Analyst Notes on Gilead, Biogen Idec, Amgen, Illumina and MannKind 5:20 a.m. July 4, 2014 - PR Newswire - PRF
MannKind Corp Analyst Report; Afrezza is Approved and Future Developments by BrokerBank Securities, Inc. 11:15 a.m. July 3, 2014 - PR Newswire - PRF
Critical Alerts For MannKind, AOL, Plug Power, Ctrip.com, and 58.com Released By InvestorsObserver 9:31 a.m. July 1, 2014 - PR Newswire - PRF
MannKind Corporation Announces FDA Approval of AFREZZA(R); A Novel, Rapid-Acting Inhaled Insulin for the Treatment of Diabetes 5:07 p.m. June 27, 2014 - GlobeNewswire
Leadership Appointments, Approved Acquisitions, Licensing Agreements, Technical UPdate, and Response to Tender Offer Announcement - Analyst Notes on Actavis, Forest, Vertex, MannKind and Gentiva 5:20 a.m. June 26, 2014 - PR Newswire - PRF
Critical Alerts For Netflix, MannKind, Dish Network, Illumina, and Anheuser-Busch InBev Technology Released By InvestorsObserver 9:31 a.m. June 6, 2014 - PR Newswire - PRF
MannKind to Present at Upcoming Conferences 9:01 a.m. May 27, 2014 - GlobeNewswire
Reveal Insider Trading for Facebook, MannKind, QUALCOMM, American Realty Capital Properties, salesforce.com, and Symantec 8:55 a.m. May 22, 2014 - PR Newswire - PRF
Technical Data on Top Gainers -- Research on MannKind, Intermolecular, FireEye, and Yingli Green Energy Holding 9:10 a.m. May 20, 2014 - PR Newswire - PRF
Earnings Release Results, and Leadership Appointments - Analyst Notes on Halozyme, MannKind, Arrowhead, Idera and BioCryst 7:00 a.m. May 16, 2014 - PR Newswire - PRF
Critical Alerts For Citigroup, Linn Energy, MannKind, Canadian Solar, and Qualcomm Released By InvestorsObserver 9:31 a.m. May 15, 2014 - PR Newswire - PRF
MannKind Corporation Pending FDA Approval Inspires Analyst Report by BrokerBank Securities, Inc. 8:00 a.m. May 14, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼